Synthesis and characterization of novel astragalin galactosides using β-galactosidase from Bacillus circulans

Enzyme and Microbial Technology

Volumn 103, Issue , 2017, Pages 59-67

  Han, Songhee ^a   Hanh Nguyen, Thi Thanh ^a   Hur, Jaewon ^a   Kim, Nahyun M ^b   Kim, Seong Bo ^c   Hwang, Kyeong Hwan ^d   Moon, Young Hwan ^e   Kang, Choongil ^f   Chung, Byoungsang ^f   Kim, Young Min ^g   Kim, Tae Sung ^h   Park, Jun Seong ^d   Kim, Doman ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CJ Corporation   (South Korea)

^d AmorePacific Corporation   (South Korea)

^e Audubon Sugar Institute   (United States)

^f OTTOGI Corporation   (South Korea)

^g Chonnam National University   (South Korea)

^h Korea University   (South Korea)

Author keywords

ACE inhibition; Antioxidant activity; Astragalin; Astragalin galactoside; Galactosidase

Indexed keywords

BACTERIOLOGY; COLUMN CHROMATOGRAPHY; ION EXCHANGE; NUCLEAR MAGNETIC RESONANCE; PLANTS (BOTANY); SOLUBILITY;

ACE INHIBITION; ANTI-OXIDANT ACTIVITIES; ASTRAGALIN; ASTRAGALIN GALACTOSIDE; GALACTOSIDASES;

FLAVONOIDS;

ASTRAGALIN; BETA GALACTOSIDASE; GALACTOSIDE; KAEMPFEROL 3 O BETA DEXTRO GLUCOPYRANOSYL (1,6) BETA DEXTRO GALACTOPYRANOSIDE; KAEMPFEROL 3 O BETA DEXTRO GLUCOPYRANOSYL (1,6) BETA GALACTOPYRANOSYL (1,4) BETA DEXTRO GALACTOPYRANOSIDE; SILICON DIOXIDE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KAEMPFEROL DERIVATIVE; SCAVENGER;

ARTICLE; BACILLUS CIRCULANS; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SYNTHESIS; ENZYME STRUCTURE; ENZYME SUBSTRATE; IC50; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; BACILLUS; BIOSYNTHESIS; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; HEK293 CELL LINE; HUMAN; METABOLISM; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUBILITY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BACILLUS; BACTERIAL PROTEINS; BETA-GALACTOSIDASE; CELL SURVIVAL; FREE RADICAL SCAVENGERS; GALACTOSIDES; HEK293 CELLS; HUMANS; INDUSTRIAL MICROBIOLOGY; KAEMPFEROLS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; SOLUBILITY;

EID: 85019914830     PISSN: 01410229     EISSN: 18790909     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2017.05.003     Document Type: Article

References (38)

1. Liu, Q., Zhang, Y.J., Yang, C.R., Xu, M., Phenolic antioxidants from green tea produced from Camellia crassicolumna Var multiplex. J. Agric. Food Chem. 59 (2009), 586–590.
2. Choi, J., Kang, H.J., Kim, S.Z., Kwon, T.O., Jeong, S.-I., Jang, S.I., Antioxidant effect of astragalin isolated from the leaves of Morus alba L. against free radical-induced oxidative hemolysis of human red blood cells. Arch. Pharmacal. Res. 36 (2013), 912–927.
3. Matsumoto, M., Kotani, M., Fujita, A., Higa, S., Kishimoto, T., Suemura, M., Tanaka, T., Oral administration of persimmon leaf extract ameliorates skin symptoms and transepidermal water loss in atopic dermatitis model mice, NC/Nga. Br. J. Deematol. 146 (2002), 221–227.
4. Kim, M.-S., Kim, S.-H., Inhibitory effect of astragalin on expression of lipopolysaccharide-induced inflammatory mediators through NF-κB in macrophages. Arch. Pharmacal. Res. 34 (2011), 2101–2107.
5. Le Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D.C., Yessine, M.A., Ranger, M., Leroux, J.-C., Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J. Controlled Release 99 (2004), 83–101.
6. Savjani, K.T., Gajjar, A.K., Savjani, J.K., Drug solubility: importance and enhancement techniques. ISRN Pharm., 2012, 2012, 195727.
7. Moon, Y.H., Lee, J.H., Ahn, J.S., Nam, S.H., Oh, D.K., Park, D.H., Chung, H.J., Kang, S., Day, D.F., Kim, D., Synthesis structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB. J. Agric. Food Chem. 54 (2006), 1230–1237.
8. Harada, N., Inagaki, N., Role of sodium-glucose transporters in glucose uptake of the intestine and kidney. J. Diabetes Investig. 3 (2012), 352–353.
9. Kim, G.-E., Kang, H.-K., Seo, E.-S., Jung, S.-H., Park, J.-S., Kim, D.-H., Kim, D.-W., Ahn, S.-A., Sunwoo, C., Kim, D., Glucosylation of the flavonoid, astragalin by Leuconostoc mesenteroides B-512FMCM dextransucrase acceptor reactions and characterization of the products. Enzyme Microb. Technol. 50 (2012), 50–56.
10. George Thompson, A.M., Iancu, C.V., Nguyen, T.T.H., Kim, D., Choe, J.-Y., Inhibition of human GLUT1 and GLUT5 by plant carbohydrate products; insights into transport specificity. Sci. Rep., 5, 2015, 12804.
11. Pivarnik, L.F., Senecal, A.G., Rand, A.G., Hydrolytic and transgalactosylic activities of commercial beta-galactosidase (lactase) in food processing. Adv. Food Nutr. Res. 38 (1995), 1–102.
12. Adam, A.C., Rubio-Texeira, M., Polaina, J., Lactose The milk sugar from a biotechnological perspective. Crit. Rev. Food. Sci. Nutr. 44 (2005), 553–557.
13. Park, H.-Y., Kim, H.-J., Lee, J.-K., Kim, D., Oh, D.-K., Galactooligosaccharide production by a thermostable β-galactosidase from Sulfolobus solfataricus. World J. Microbiol. Biotechnol. 24 (2008), 1553–1558.
14. Rodriguez-Colinas, B., Poveda, A., Jimenez-Barbero, J., Ballesteros, A.O., Plou, F.J., Galacto-oligosaccharide synthesis from lactose solution or skim milk using the β-galactosidase from Bacillus circulans. J. Agric. Food Chem. 60 (2012), 6391–6398.
15. Urrutia, P., Rodriguez-Colinas, B., Fernandez-Arrojo, L., Ballesteros, A.O., Wilson, L., Illanes, A., Plou, F.J., Detailed analysis of galactooligosaccharides synthesis with β-galactosidase from Aspergillus oryzae. J. Agric. Food Chem. 61 (2013), 1081–1087.
16. Palai, T., Mitra, S., Bhattacharya, P.K., Kinetics and design relation for enzymatic conversion of lactose into galacto-oligosaccharides using commercial grade β-galactosidase. J. Biosci. Bioeng. 114 (2012), 418–423.
17. Gosling, A., Stevens, G.W., Barber, A.R., Kentish, S.E., Gras, S.L., Effect of the substrate concentration and water activity on the yield and rate of the transfer reaction of β-galactosidase from Bacillus circulans. J. Agric. Food Chem. 56 (2011), 3366–3372.
18. Song, J., Abe, K., Imanaka, H., Imamura, K., Minoda, M., Yamaguchi, S., Nakanishi, K., Causes of the production of multiple forms of β-galactosidase by Bacillus circulans. Biosci. Biotechnol. Biochem. 75 (2011), 268–278.
19. Li, W., Xiang, X., Tang, S., Hu, B., Tian, L., Sun, Y., Ye, H., Zeng, X., Effective enzymatic synthesis of lactosucrose and its analogues by β-D-galactosidase from Bacillus circulans. J. Agric. Food Chem. 57 (2009), 3927–3933.
20. Bridiau, N., Issaoui, N., Maugard, T., The effects of organic solvents on the efficiency and regioselectivity of N-acetyl-lactosamine synthesis, using the β-galactosidase from Bacillus circulans in hydro-organic media. Biotechnol. Prog. 26 (2010), 1278–1289.
21. Usui, T., Kubota, S., Ohi, H., A convenient synthesis of (-D-galactosyl disaccharide derivatives using the β-D-galactosidase from Bacillus circulans. Carbohydr. Res. 244 (1993), 315–323.
22. Farkas, E., Schmidt, U., Thiem, J., Kowalczyk, J., Kunz, M., Vogel, M., Regioselective synthesis of galactosylated tri- and tetrasaccharides by use of beta-galactosidase from Bacillus circulans. Synth. Stuttg. 699 (2003), 699–706.
23. Kang, J., Kim, Y.M., Kim, N., Kim, D.W., Nam, S.H., Kim, D., Synthesis and characterization of hydroquinone fructoside using Leuconostoc mesenteroides levansucrase. Appl. Microbiol. Biotechnol. 83 (2009), 1009–1016.
24. Re, R., Pellegrini, N., Proteggente, A., Pannala, A., Yang, M., Rice-Evans, C., Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26 (1999), 1231–1237.
25. Li, G.-H., Liu, H., Shi, Y.-H., Le, G.-W., Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides. J. Pharm. Biomed. Anal. 37 (2005), 219–224.
26. Kim, J., Nguyen, T.T.H., Kim, N.M., Moon, Y.H., Ha, J.M., Park, N., Lee, D.G., Hwang, K.H., Park, J.S., Kim, D., Functional properties of novel epigallocatechin gallate glucosides synthesized by using dextransucrase from Leuconostoc mesenteroides B-1299CB4. J. Agric. Food Chem. 64:48 (2016), 9203–9213.
27. Valko, M., Rhodes, C.J., Moncol, J., Izakovic, M., Mazur, M., Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006), 1–40.
28. Parthasarathy, S., Santanam, N., Ramachandran, S., Meilhac, O., Oxidants and antioxidants in atherogenesis. An appraisal. J. Lipid Res. 40 (1999), 2143–2157.
29. Manea, A., Fortuno, A., Martin-Ventura, J.L., Oxidative stress in cardiovascular pathologies: genetics, cellular, and molecular mechanisms and future antioxidant therapies. Oxid. Med. Cell. Longevity, 2012, 2012, 373450.
30. Masaki, H., Role of antioxidants in the skin: anti-aging effects. J. Dermatol. Sci. 58 (2010), 85–90.
31. Ondetti, M.A., Rubin, B., Cushman, D.W., Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196 (1977), 441–444.
32. Coates, D., The angiotensin converting enzyme (ACE). Int. J. Biochem. Cell Biol. 35 (2003), 769–773.
33. Shlipak, M.G., Browner, W.S., Noguchi, H., Massie, B., Frances, C.D., McClellan, M., Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am. J. Med. 110 (2001), 425–433.
34. Carson, P.E., Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure. Am. Heart J. 140 (2000), 361–366.
35. Kameda, K., Takaku, T., Okuda, H., Kimura, Y., Okuda, T., Hatano, T., Agata, I., Arichi, S., Inhibitory effects of various flavonoids isolated from leaves of persimmon on Angiotensin-Converting Enzyme activity. J. Nat. Prod. 50 (1987), 680–683.
36. Galati, G., Sabzevari, O., Wilson, J.X., O'Brien, P.J., Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 177:1 (2002), 91–104.
37. Guan, R., Kang, T., Lu, F., Zhang, Z., Shen, H., Liu, M., Cytotoxicity, oxidative stress, and genotoxicity in human hepatocyte and embryonic kidney cells exposed to ZnO nanoparticles. Nanoscale Res. Lett., 7(1), 2012, 602.
38. Selvaraj, V., Bodapati, S., Murray, E., Rice, K.M., Winston, N., Shokuhfar, T., Zhao, Y., Blough, E., Cytotoxicity and genotoxicity caused by yttrium oxide nanoparticles in HEK293 cells. Int. J. Nanomed. 9 (2014), 1379–1391.